Maria Paola Costi
SEEK ID: https://fairdomhub.org/people/1969
Location:
Italy
ORCID:
https://orcid.org/0000-0002-0443-5402
Joined: 30th Mar 2021
Expertise: Not specified
Tools: Not specified
Project roles
Their tagsNMTrypI - New Medicines for Trypanosomatidic Infections (Università degli Studi di Modena e Reggio Emilia (UNIMORE)) ; Mass spectrometry proteomics for biomarker discovery (Università degli Studi di Modena e Reggio Emilia (UNIMORE)) ; Thymidylate synthase dimer dissociation (Università degli Studi di Modena e Reggio Emilia (UNIMORE))
Related items
Projects: Mass spectrometry proteomics for biomarker discovery, TEAD-(YAP) structure, function and inhibition, Thymidylate synthase dimer dissociation
Web page: Not specified
Projects: NMTrypI - New Medicines for Trypanosomatidic Infections
Web page: https://cordis.europa.eu/programme/id/FP7_HEALTH.2013.2.3.4-2
The New Medicines for Trypanosomatidic Infections - NMTrypI project aimed at obtaining new candidate drugs against Trypanosomatidic infections with appropriate efficiency from the lead phase to the final preclinical phase that are more accessible to patients.
Programme: Drug development for neglected parasitic diseases
Public web page: https://fp7-nmtrypi.eu/
Start date: 1st Feb 2014
End date: 31st Jan 2017
Programme: Cancer drug discovery preclinical research
Public web page: Not specified
Programme: Cancer drug discovery preclinical research
Public web page: Not specified
Semi-targeted Mass Spectrometry proteomics study to detect 12 selected proteins of two serum samples belonging to the FOLFOX-4 study on heavly-pretreated ovarian cancer patients. The two samples, F10 and F12, are basal samples collected at before the first FOLFOX-4 treatment cycle (T0) and were selected for this study because they show a different proteome profile.
Download
Supplementary material for "Mass spectrometry proteomic and network enrichment analysis to track FOLFOX response in drug resistant ovarian carcinoma"
